Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Sparing Intradermal Influenza Vaccination with MicronJet
NCT01304563Phase 2Completed
- Sponsor
- The University of Hong Kong
- Start
- Nov 2010
- Primary completion
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of IDflu in influenza, sponsored by The University of Hong Kong. Started Nov 2010; status: completed.
02
Drugs
IDflu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01304563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01304563.